Eli Lilly's OMVOH drug achieves primary endpoint in pediatric ulcerative colitis trial
智通财经2026/10/19 09:01Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Market news: Eli Lilly's (LLY.US) OMVOH drug achieved the primary endpoint in a pediatric ulcerative colitis trial.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Tesla: Musk's 2025 compensation includes $158.36 billions in stock awards
智通财经•2026/10/19 10:42
Citi lowers Bank of New York Mellon's target price to $157
智通财经•2026/10/19 10:26
Crypto prices
More
Bitcoin
BTC
$82,371.93
+0.43%
Ethereum
ETH
$2,424.86
+0.30%
Tether USDt
USDT
$0.9989
+0.03%
BNB
BNB
$723.75
+0.15%
XRP
XRP
$1.3
+0.53%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$104.88
+0.91%
TRON
TRX
$0.3308
-0.65%
Hyperliquid
HYPE
$79.35
+0.50%
Zcash
ZEC
$1,141.6
+0.93%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now